These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 22652676

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G, Yildizhan R.
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S, Kaitu'u-Lino TJ, Onda K, Beard S, Hastie R, Binder NK, Cluver C, Tuohey L, Whitehead C, Brownfoot F, De Silva M, Hannan NJ.
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [Abstract] [Full Text] [Related]

  • 7. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B, Thornton C, Tooher J, Ogle R, Lim S, Makris A, Hennessy A.
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [Abstract] [Full Text] [Related]

  • 8. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ, Brownfoot FC, Hastie R, Chand A, Cannon P, Deo M, Tuohey L, Whitehead C, Hannan NJ, Tong S.
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [Abstract] [Full Text] [Related]

  • 9. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N, Naicker T, Rajakumar A, Moodley J.
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [Abstract] [Full Text] [Related]

  • 10. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D, Biris D, Karampitsakos T, Nicolaides KK, Kametas NA.
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [Abstract] [Full Text] [Related]

  • 11. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A.
    Circulation; 2007 Apr 03; 115(13):1789-97. PubMed ID: 17389265
    [Abstract] [Full Text] [Related]

  • 12. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec 03; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 13. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.
    Circulation; 2010 Aug 03; 122(5):478-87. PubMed ID: 20644016
    [Abstract] [Full Text] [Related]

  • 14. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
    Gu Y, Lewis DF, Wang Y.
    J Clin Endocrinol Metab; 2008 Jan 03; 93(1):260-6. PubMed ID: 17956952
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK, Chandel N, Jain V, Jha V.
    J Hum Hypertens; 2012 Apr 03; 26(4):236-41. PubMed ID: 21451568
    [Abstract] [Full Text] [Related]

  • 17. Evidence-Based Revised View of the Pathophysiology of Preeclampsia.
    Ahmed A, Rezai H, Broadway-Stringer S.
    Adv Exp Med Biol; 2017 Apr 03; 956():355-374. PubMed ID: 27873232
    [Abstract] [Full Text] [Related]

  • 18. Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders.
    Khalil A, Muttukrishna S, Harrington K, Jauniaux E.
    PLoS One; 2008 Jul 23; 3(7):e2766. PubMed ID: 18648513
    [Abstract] [Full Text] [Related]

  • 19. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K, Bajracharya S, Salahuddin S, Berg AH, Geahchan C, Wenger JB, Thadhani R, Karumanchi SA, Rana S.
    Am J Obstet Gynecol; 2016 Jul 23; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [Abstract] [Full Text] [Related]

  • 20. Microvascular function in pre-eclampsia is influenced by insulin resistance and an imbalance of angiogenic mediators.
    Ghosh A, Freestone NS, Anim-Nyame N, Arrigoni FIF.
    Physiol Rep; 2017 Apr 23; 5(8):. PubMed ID: 28455450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.